Search results for "Review"

showing 10 items of 4492 documents

Autism and carnitine: A possible link

2019

Patients with autism spectrum disorders (ASD) present deficits in social interactions and communication, they also show limited and stereotypical patterns of behaviors and interests. The pathophysiological bases of ASD have not been defined yet. Many factors seem to be involved in the onset of this disorder. These include genetic and environmental factors, but autism is not linked to a single origin, only. Autism onset can be connected with various factors such as metabolic disorders: including carnitine deficiency. Carnitine is a derivative of two amino acid lysine and methionine. Carnitine is a cofactor for a large family of enzymes: the carnitine acyltransferases. Through their action th…

0301 basic medicineAutismMetabolic homeostasisBioinformatics03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCarnitinemental disordersmedicineDietary supplementationCarnitineMethioninebusiness.industryCarnitine AcyltransferasesMinireviewsmedicine.diseaseMetabolism disorderMetabolism030104 developmental biologychemistry030220 oncology & carcinogenesisPathophysiological basesNeurodevelopmentalAutismbusinessmedicine.drugWorld Journal of Biological Chemistry
researchProduct

FMF is not always "fever": from clinical presentation to "treat to target".

2020

AbstractFamilial Mediterranean Fever, a monogenic autoinflammatory disease secondary to MEFV gene mutations in the chromosome 16p13, is characterized by recurrent self-limiting attacks of fever, arthritis, aphthous changes in lips and/or oral mucosa, erythema, serositis. It is caused by dysregulation of the inflammasome, a complex intracellular multiprotein structure, commanding the overproduction of interleukin 1. Familial Mediterranean Fever can be associated with other multifactorial autoinflammatory diseases, as vasculitis and Behçet disease.Symptoms frequently start before 20 years of age and are characterized by a more severe phenotype in patients who begin earlier.Attacks consist of …

0301 basic medicineAutoinflammatory diseasemedicine.medical_specialtyCanakinumabAutoinflammatory diseasesArthritisFamilial Mediterranean feverDiseaseReviewGene mutationFamilial Mediterranean feverDiagnosis Differential03 medical and health sciences0302 clinical medicineMedicineHumansChild030203 arthritis & rheumatologybusiness.industryAmyloidosislcsh:RJ1-570lcsh:Pediatricsmedicine.diseaseMEFVDermatologyTubulin ModulatorsCanakinumab030104 developmental biologyPhenotypebusinessColchicineSerositisBiomarkersmedicine.drugItalian journal of pediatrics
researchProduct

How Glutamate Is Managed by the Blood-Brain Barrier.

2016

A facilitative transport system exists on the blood–brain barrier (BBB) that has been tacitly assumed to be a path for glutamate entry to the brain. However, glutamate is a non-essential amino acid whose brain content is much greater than plasma, and studies in vivo show that glutamate does not enter the brain in appreciable quantities except in those small regions with fenestrated capillaries (circumventricular organs). The situation became understandable when luminal (blood facing) and abluminal (brain facing) membranes were isolated and studied separately. Facilitative transport of glutamate and glutamine exists only on the luminal membranes, whereas Na+-dependent transport systems for g…

0301 basic medicineBBB (blood–brain barrier)brainglutamateReviewBiologyBlood–brain barrierGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineExtracellular fluidmedicinelcsh:QH301-705.5Circumventricular organsoxoprolinechemistry.chemical_classificationGeneral Immunology and Microbiologyamino acid transportGlutamate receptorAmino acidGlutamine030104 developmental biologymedicine.anatomical_structureMembranelcsh:Biology (General)BiochemistrychemistryBiophysicsglutamineGeneral Agricultural and Biological SciencesCotransporter030217 neurology & neurosurgeryBiology
researchProduct

NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.

2020

Metabolomics, the research area studying chemical processes involving metabolites, finds its utility in inflammasome biomarker discovery, thus representing a novel approach for cardiometabolic syndrome pathogeny acknowledgements. Metabolite biomarkers discovery is expected to improve the disease evolution and outcome. The activation of abundantly expressed NLRP3 inflammasome represents the background process of the diabetes mellitus disturbances like hyperglycemia and insulin resistance, as well as for myocardial cell death and fibrosis, all of them being features characteristic for cardiometabolic syndrome. Many molecules like troponins, brain natriuretic protein (BNP), ST2/IL-33, C-reacti…

0301 basic medicineBiomarkers Cardiometabolic syndrome Inflammasome Metabolomics NLRP3 inflammasome Outcome Targeted therapyMyocarditisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentReviewBioinformaticsBiochemistryTargeted therapy03 medical and health sciences0302 clinical medicineInsulin resistanceinflammasomeDiabetes mellitusmedicineMyocardial infarctionBiomarker discoveryMolecular Biologybusiness.industrybiomarkersInflammasomemedicine.diseasetargeted therapymetabolomicsNLRP3 inflammasome030104 developmental biology030220 oncology & carcinogenesisoutcomeBiomarker (medicine)cardiometabolic syndromebusinessmedicine.drugMetabolites
researchProduct

Deep learning in next-generation sequencing

2020

Highlights • Machine learning increasingly important for NGS. • Deep learning can improve many NGS applications.

0301 basic medicineBiomedical ResearchComputer scienceContext (language use)ComputerApplications_COMPUTERSINOTHERSYSTEMSReviewMachine learningcomputer.software_genre03 medical and health sciences0302 clinical medicineDeep LearningGene to ScreenDrug DiscoveryHumansPharmacologyFeature detection (web development)Network architectureArtificial neural networkbusiness.industryDeep learningHigh-Throughput Nucleotide SequencingMedical research030104 developmental biologyMetagenomics030220 oncology & carcinogenesisUnsupervised learningArtificial intelligenceMetagenomicsNeural Networks ComputerbusinesscomputerDrug Discovery Today
researchProduct

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

2020

TP53 missense mutations leading to the expression of mutant p53 oncoproteins are frequent driver events during tumorigenesis. p53 mutants promote tumor growth, metastasis and chemoresistance by affecting fundamental cellular pathways and functions. Here, we demonstrate that p53 mutants modify structure and function of the Golgi apparatus, culminating in the increased release of a pro-malignant secretome by tumor cells and primary fibroblasts from patients with Li-Fraumeni cancer predisposition syndrome. Mechanistically, interacting with the hypoxia responsive factor HIF1α, mutant p53 induces the expression of miR-30d, which in turn causes tubulo-vesiculation of the Golgi apparatus, leading …

0301 basic medicineBiopsyGeneral Physics and AstronomyGolgi ApparatusAnimals Biopsy Breast Neoplasms Cell Line Tumor Cell Transformation Neoplastic Female Fibroblasts Gene Expression Regulation Neoplastic Golgi Apparatus Humans Hypoxia-Inducible Factor 1 alpha Subunit Li-Fraumeni Syndrome Mice MicroRNAs Microtubules Mutation Primary Cell Culture Secretory Vesicles Signal TransductionSkin Tumor Microenvironment Tumor Suppressor Protein p53 Xenograft Model Antitumor Assays02 engineering and technologymedicine.disease_causeCell TransformationMicrotubulesSettore BIO/09 - FisiologiaMetastasisLi-Fraumeni SyndromeMiceTumor MicroenvironmentGolgisecretory machinerySuper-resolution microscopyAnimals; Biopsy; Breast Neoplasms; Cell Line Tumor; Cell Transformation Neoplastic; Female; Fibroblasts; Gene Expression Regulation Neoplastic; Golgi Apparatus; Humans; Hypoxia-Inducible Factor 1 alpha Subunit; Li-Fraumeni Syndrome; Mice; MicroRNAs; Microtubules; Mutation; Primary Cell Culture; Secretory Vesicles; Signal Transduction; Skin; Tumor Microenvironment; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assayslcsh:ScienceSkinMultidisciplinaryTumorChemistrymutant p53QCell migrationMicroRNASecretomics021001 nanoscience & nanotechnologyCell biologyGene Expression Regulation NeoplasticCell Transformation NeoplasticsymbolsFibroblastmiR-30dFemaleHypoxia-Inducible Factor 10210 nano-technologyBreast NeoplasmHumanSignal TransductionCancer microenvironmentStromal cellSecretory VesicleSciencePrimary Cell CultureBreast NeoplasmsMicrotubuleGolgi ApparatuSettore MED/08 - Anatomia Patologicaalpha SubunitGeneral Biochemistry Genetics and Molecular BiologyArticleCell Line03 medical and health sciencessymbols.namesakeCell Line TumormedicineAnimalsHumansSettore MED/05 - Patologia ClinicaSecretionTumor microenvironmentNeoplasticAnimalSecretory VesiclesGeneral ChemistryOncogenesGolgi apparatusHDAC6FibroblastsMicroreviewHypoxia-Inducible Factor 1 alpha SubunitmicroenvironmentXenograft Model Antitumor AssaysMicroRNAs030104 developmental biologyGene Expression RegulationMutationlcsh:QTumor Suppressor Protein p53Carcinogenesis
researchProduct

Curcumin as a therapeutic option in retinal diseases

2020

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2076-3921/9/1/48 Este artículo pertenece al número especial "Natural products in health promotion and disease prevention". En este artículo también participa: Vincent M. Villar. The retina is subjected to oxidative stress due to its high vascularization, long time light exposition and a high density of mitochondria. Oxidative stress can lead to pathological processes, like cell apoptosis, angiogenesis and inflammation ending in retinal pathologies. Curcumin, a major bioactive component obtained from the spice turmeric (Curcuma longa) rhizome has been used for centuries in Asian countries for cooking and for curi…

0301 basic medicineBioquímicaretinaAntioxidantPhysiologyBioquímica clínicamedicine.medical_treatmentClinical BiochemistryCurcumina - Uso terapéutico.InflammationReviewPharmacologyMitochondrionmedicine.disease_causeBiochemistryRetina03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineoxidative stresscurcuminCurcumaMolecular BiologyVistachemistry.chemical_classificationEstrés oxidativo.Reactive oxygen speciesBiología molecularbiologybusiness.industryRetina - Diseases - Treatment.lcsh:RM1-950RetinalCell Biologybiology.organism_classificationCurcumin - Therapeutic use.Oxidative stress.030104 developmental biologylcsh:Therapeutics. Pharmacologyretinal diseaseschemistry030220 oncology & carcinogenesisCurcuminmedicine.symptombusinessCúrcumaOxidative stressRetina - Enfermedades - Tratamiento.
researchProduct

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines

2018

As an important source for traditional medical systems such as Ayurvedic medicine and traditional Chinese medicine, herbal medicines have received widespread attentions from all over the world, especially in developing countries. Over the past decade, studies on gut microbiota have generated rich information for understanding how gut microbiota shape the functioning of our body system. In view of the importance of gut microbiota, the researchers engaged in studying herbal medicines have paid more and more attention to gut microbiota and gut microbiota metabolites. Among a variety of gut microbiota metabolites, short-chain fatty acids (SCFAs) have received most attention because of their imp…

0301 basic medicineBody systemPharmacologyAyurvedic medicineTraditional medicinegut microbiotaMini Reviewshort-chain fatty acidslcsh:RM1-950Traditional Chinese medicineBiologyGut florabiology.organism_classificationdigestive system03 medical and health sciencestraditional Chinese medicine030104 developmental biologylcsh:Therapeutics. Pharmacologyherbal medicinesPharmacology (medical)metabolitesMedical systemsFrontiers in Pharmacology
researchProduct

Emerging insights on the biological impact of extracellular vesicle-associated ncRNAs in multiple Myeloma

2020

Increasing evidence indicates that extracellular vesicles (EVs) released from both tumor cells and the cells of the bone marrow microenvironment contribute to the pathobiology of multiple myeloma (MM). Recent studies on the mechanisms by which EVs exert their biological activity have indicated that the non-coding RNA (ncRNA) cargo is key in mediating their effect on MM development and progression. In this review, we will first discuss the role of EV-associated ncRNAs in different aspects of MM pathobiology, including proliferation, angiogenesis, bone disease development, and drug resistance. Finally, since ncRNAs carried by MM vesicles have also emerged as a promising tool for early diagnos…

0301 basic medicineBone diseaselcsh:QH426-470AngiogenesisReviewBiologyBiochemistry03 medical and health sciences0302 clinical medicineMultiple myelomaGeneticsmedicineNon-coding RNAMolecular BiologyMultiple myelomaRNAbiomarkersBiological activityExtracellular vesicleBiomarkermedicine.diseaseNon-coding RNAlcsh:Genetics030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisDrug resistanceCancer researchBone marrowprogressionExtracellular vesicleextracellular vesicles
researchProduct

The Effects of Early Life Stress on the Brain and Behaviour: Insights From Zebrafish Models

2021

The early life period represents a window of increased vulnerability to stress, during which exposure can lead to long-lasting effects on brain structure and function. This stress-induced developmental programming may contribute to the behavioural changes observed in mental illness. In recent decades, rodent studies have significantly advanced our understanding of how early life stress (ELS) affects brain development and behaviour. These studies reveal that ELS has long-term consequences on the brain such as impairment of adult hippocampal neurogenesis, altering learning and memory. Despite such advances, several key questions remain inadequately answered, including a comprehensive overview…

0301 basic medicineBrain developmentBrain activity and meditationQH301-705.5Early life stressBrain Structure and Functionbrain developmentReviewHippocampal formation03 medical and health sciencesCell and Developmental Biology0302 clinical medicinemedicineBiology (General)ZebrafishbiologyHPA axisNeurogenesisCell BiologyMental illnessmedicine.diseasebiology.organism_classificationzebrafishearly life stress (ELS)behaviour030104 developmental biologyNeuroscience030217 neurology & neurosurgeryDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct